| || |
H. David Humes, MD
Professor of Internal Medicine
University of Michigan Medical School
Ann Arbor, MI USA
Dr. Humes graduated from the medical school of the University of California, San Francisco, where he stayed to complete his internship and residency training. He spent a year as a Clinical Fellow in Nephrology at the Hospital of the University of Pennsylvania and then another year as a Research Fellow in the Laboratory of Kidney and Electrolyte Physiology at Peter Bent Brigham Hospital in Boston. He joined the faculty at Harvard Medical School as an Instructor and departed Harvard as an Assistant Professor of Medicine. The University of Michigan recruited Dr. Humes as an Assistant Professor of Internal Medicine. After rising quickly through the faculty ranks, he became a full Professor and then the John G. Searle Professor and Chair of the Department of Internal Medicine, a position he held until 2000. Since joining the faculty of the University of Michigan Department of Internal Medicine, Dr. Humes has served many roles, including Director of the Nephrology Research Laboratories, Chief of the Nephrology Section at the VA Medical Center, Chief of the Medical Service at the VA Medical Center, Acting Chief of Staff at the VA Medical Center, and Associate Chair of the Department. Dr. Humes is a member of the editorial board of five scientific journals. He has published approximately 180 scientific papers and has edited numerous textbooks, including, and most recently, Kelley’s Textbook of Internal Medicine. Additionally, he has 40 patents issued or pending. He is an international authority in the areas of acute renal failure, stem cell biology, and tissue engineering and has received NIH funding for over twenty years. Recently, his laboratory received national and international attention for its work in the development of the bioartificial kidney. Dr. Humes has been elected to a number of prestigious honorary scientific societies, including Alpha Omega Alpha; Fellow, American College of Physicians; American Society of Clinical Investigation; Association of American Physicians; and Fellow, American Association for the Advancement of Science. A number of highly acclaimed awards in Nephrology have been bestowed on him, including The President’s Award from the National Kidney Foundation and the A.N. Richards Distinguished Achievement Award in Nephrology. Dr. Humes is active in the for-profit sector, with involvement in several start-up companies. Most notably, he is the scientific founder of CytoPherx (formerly Nephrion, Inc. and RenaMed Biologics, Inc.), a biotechnology company directed toward various devices to treat acute organ failure; and Innovative BioTherapies, Inc., a company developing nanofabricated replacement organs. He is also on the Medical Advisory Boards of Renal Solutions, Inc., and Natural Therapeutics, Inc.